Vitamin D and cognitive function

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 72, Issue SUPPL. 243, 2012, Pages 79-82

  Soni, Maya ^a   Kos, Katarina ^a   Lang, Iain A ^a,b   Jones, Kerry ^a   Melzer, David ^a   Llewellyn, David J ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b NATIONAL HEALTH SERVICE   (United Kingdom)

Author keywords

Alzheimer's disease; Calcitriol; Cognition; Cognitive decline; Dementia

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; NEUROTROPHIC FACTOR; VITAMIN D; VITAMIN D RECEPTOR; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANGIOCARDIOGRAPHY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BRAIN TISSUE; CALCIUM HOMEOSTASIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); COGNITION; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DEMENTIA; DIABETES MELLITUS; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE COURSE; EUROPE; GENE EXPRESSION; HUMAN; HYPERTENSION; LIQUID CHROMATOGRAPHY; METABOLIC DISORDER; NEOPLASM; NERVE CELL; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; RISK ASSESSMENT; STROKE; TANDEM MASS SPECTROMETRY; UPREGULATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; AGING; ANIMAL; BLOOD; BRAIN; PHYSIOLOGY; REVIEW;

AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; COGNITION; DEMENTIA; HUMANS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84860380322     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2012.681969     Document Type: Article

References (47)

1. Grant WB. Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol 2006;92: 65-79.
2. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: Serum vitamin D and colorectal adenoma risk. Prev Med 2011;53:10-6.
3. Grandi NC, Breitling LP, Brenner H. Vitamin D and cardiovascular disease: Systematic review and meta-analysis of prospective studies. Prev Med 2010;51:228-33.
4. Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia 2005;48:1247-57.
5. Poole KE, Loveridge N, Barker PJ, Halsall DJ, Rose C, Reeve J, Warburton EA. Reduced vitamin D in acute stroke. Stroke 2006;37:243-5.
6. Grant WB. Does vitamin D reduce the risk of dementia? J Alzheimers Dis 2009;17:151-9.
7. Pogge E. Vitamin D and Alzheimer's disease: is there a link? The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 2010;25:440-50.
8. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang YQ, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M, Alzheimers Dis I. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112-7.
9. Dewey ME, Saz P. Dementia, cognitive impairment and mortality in persons aged 65 and over living in the community: a systematic review of the literature. Int J Geriatr Psychiatry 2001;16:751-61.
10. Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, Booker L, Oremus M. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med 2008;148:379-97.
11. Rodda J, Morgan S, Walker Z. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. Int Psychogeriatr 2009;21:813-24.
12. Annweiler C, Souberbielle JC, Schott AM, de Decker L, Berrut G, Beauchet O. [Vitamin D in the elderly: 5 points to remember]. Geriatr Psychol Neuropsychiatr Vieil 2011; 9:259-67.
13. Sutherland MK, Somerville MJ, Yoong LK, Bergeron C, Haussler MR, McLachlan DR. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Brain Res Mol Brain Res 1992;13:239-50.
14. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005;29:21-30.
15. L ue LF, Kuo YM, Beach T, Walker DG. Microglia activation and anti-inflammatory regulation in Alzheimer's disease. Mol Neurobiol 2010;41:115-28.
16. Dursun E, Gezen-Ak D, Yilmazer S. A novel perspective for Alzheimer's disease: vitamin D receptor suppression by amyloid-beta and preventing the amyloid-beta induced alterations by vitamin D in cortical neurons. J Alzheimers Dis 2011;23:207-19.
17. Masoumi A, Goldenson B, Ghirmai S, Avagyan H, Zaghi J, Abel K, Zheng X, Espinosa-Jeffrey A, Mahanian M, Liu PT, Hewison M, Mizwickie M, Cashman J, Fiala M. 1alpha, 25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer's disease patients. J Alzheimers Dis 2009;17:703-17.
18. Obradovic D, Gronemeyer H, Lutz B, Rein T. Cross-talk of vitamin D and glucocorticoids in hippocampal cells. J Neurochem 2006;96:500-9.
19. Bao BY, Ting HJ, Hsu JW, Lee YF. Protective role of 1 alpha, 25-dihydroxyvitamin D3 against oxidative stress in nonmalignant human prostate epithelial cells. Int J Cancer 2008; 122:2699-706.
20. Fernandes de Abreu DA, Eyles D, Feron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 2009;34 Suppl 1:S265-77.
21. Schindowski K, Belarbi K, Buee L. Neurotrophic factors in Alzheimer's disease: role of axonal transport. Genes Brain Behav 2008;7 Suppl 1:43-56.
22. Brewer LD, Porter NM, Kerr DS, Landfield PW, Thibault O. Chronic 1alpha,25-(OH)2 vitamin D3 treatment reduces Ca2-mediated hippocampal biomarkers of aging. Cell Calcium 2006;40:277-86.
23. Brewer LD, Thibault V, Chen KC, Langub MC, Landfield PW, Porter NM. Vitamin D hormone confers neuropro tection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci 2001;21:98-108.
24. Foster TC, Kumar A. Calcium dysregulation in the aging brain. Neuroscientist 2002;8:297-301.
25. Gant JC, Sama MM, Landfield PW, Thibault O. Early and simultaneous emergence of multiple hippocampal biomarkers of aging is mediated by Ca2-induced Ca2-release. J Neurosci 2006;26:3482-90.
26. Buell JS, Dawson-Hughes B, Scott TM, Weiner DE, Dallal GE, Qui WQ, Bergethon P, Rosenberg IH, Folstein MF, Patz S, Bhadelia RA, Tucker KL. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 2010;74:18-26.
27. Pilz S, Dobnig H, Fischer JE, Wellnitz B, Seelhorst U, Boehm BO, Marz W. Low vitamin d levels predict stroke in patients referred to coronary angiography. Stroke 2008;39: 2611-3.
28. Barnard K, Colon-Emeric C. Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition. Am J Geriatr Pharmacother 2010;8:4-33.
29. Wolf PA. Stroke risk profiles. Stroke 2009;40:S73-4.
30. Brewer LC, Michos ED, Reis JP. Vitamin D in atherosclerosis, vascular disease, and endothelial function. Curr Drug Targets 2011;12:54-60.
31. Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Beauchet O. Serum vitamin D deficientcy as a predictor of incident non-Alzheimer dementias: a 7-year longitudinal study. Dement Geriatr Cogn Disord 2011;32:273-8.
32. Dickens AP, Lang IA, Langa KM, Kos K, Llewellyn DJ. Vitamin D, cognitive dysfunction and dementia in older adults. CNS Drugs 2011;25:629-39.
33. Annweiler C, Schott AM, Allali G, Bridenbaugh SA, Kressig RW, Allain P, Herrmann FR, Beauchet O. Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 2010;74:27-32.
34. Llewellyn DJ, Langa KM, Lang IA. Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol 2009;22:188-95.
35. Buell JS, Scott TM, Dawson-Hughes B, Dallal GE, Rosenberg IH, Folstein MF, Tucker KL. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 2009;64:888-95.
36. Llewellyn DJ, Lang IA, Langa KM, Melzer D. Vitamin D and cognitive impairment in the elderly U.S. population. J Gerontol A Biol Sci Med Sci 2011;66:59-65.
37. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006;14:1032-40.
38. Carter GD. Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr Drug Targets 2011;12:19-28.
39. Phinney KW. Development of a standard reference material for vitamin D in serum. Am J Clin Nutr 2008;88: 511S-2S.
40. Shea MK, Houston DK, Tooze JA, Davis CC, Johnson MA, Hausman DB, Cauley JA, Bauer DC, Tylavsky F, Harris TB, Kritchevsky SB. Correlates and prevalence of insufficient 25-hydroxyvitamin D status in black and white older adults: the health, aging and body composition study. J Am Geriatr Soc 2011;59:1165-74.
41. Chang CC, Roberts BL. Malnutrition and feeding difficulty in Taiwanese older with dementia. J Clin Nurs 2011;20: 2153-61.
42. Iwamoto J, Sato Y, Tanaka K, Takeda T, Matsumoto H. Prevention of hip fractures by exposure to sunlight and pharmacotherapy in patients with Alzheimer's disease. Aging Clin Exp Res 2009;21:277-81.
43. Sato Y, Iwamoto J, Kanoko T, Satoh K. Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in hospitalized, elderly women with Alzheimer's disease: a randomized controlled trial. J Bone Miner Res 2005;20: 1327-33.
44. Chandra RK. Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects. Nutrition 2001;17:709-12.
45. Corless D, Dawson E, Fraser F, Ellis M, Evans SJ, Perry JD, Reisner C, Silver CP, Beer M, Boucher BJ, et al. Do vitamin D supplements improve the physical capabilities of elderly hospital patients? Age Ageing 1985;14:76-84.
46. Llewellyn DJ, Lang IA, Langa KM, Muniz-Terrera G, Phillips CL, Cherubini A, Ferrucci L, Melzer D. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 2010;170:1135-41.
47. Slinin Y, Paudel ML, Taylor BC, Fink HA, Ishani A, Canales MT, Yaffe K, Barrett-Connor E, Orwoll ES, Shikany JM, LeBlanc ES, Cauley JA, Ensrud KE, St OFMM. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology 2010;74:33-41.